Immune selection during tumor checkpoint inhibition therapy paves way for NK-cell “missing self” recognition
Crossref DOI link: https://doi.org/10.1007/s00251-017-1011-9
Published Online: 2017-07-11
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Malmberg, Karl-Johan
Sohlberg, Ebba
Goodridge, Jodie P.
Ljunggren, Hans-Gustaf
Funding for this research was provided by:
Vetenskapsrådet
Kreftforeningen
Cancerfonden
Helse Sør-Øst RHF
Barncancerfonden
License valid from 2017-07-11